Thus, the level of circulating MRP-8/14/SA100A12 could potentially be employed as a biomarker to track the pathologic and radiographic progression of RA as well as clinical responses and other objective measurements to approved RA therapeutic DMARDs and/or biologic agents. The gene discussed is S100A8; the disease is rheumatoid arthritis.